Summary of cancer cell phospholipid membrane composition. Upwards arrow indicates an upregulation of specific phospholipids, downwards arrow indicates a downregulation of specific phospholipids. Where there are both upwards and downwards arrows present, this reflects the fact there will be multiple forms of a particular phospholipid present in a cell, due to different alkyl chain lengths and their degree of saturation. Some of these maybe upregulated in a cancer cell, whereas others maybe downregulated. Where ‘—’ is shown, a change in phospholipid content was either not observed or not confirmed within experimental limitations. Tissue refers to human tissue obtained from clinical samples, unless otherwise stated. The cell membranes listed here may also contain some less prevalent phospholipids. These data, alongside alkyl chain composition and, the results of studies that restrict analysis to a limited number of phospholipids, are listed in Table S2. These less common phospholipids include: L-PA, L-PC, and L-PI, L-SM. Phospholipid composition was estimated through mass spectrometry (MS).
Sample type | PC | PE | PI | PG | PS | SM | PA | Control |
---|---|---|---|---|---|---|---|---|
Lung | ||||||||
Tissue92 |
![]() |
![]() |
![]() |
— |
![]() |
![]() |
— | Matched distant lung tissue |
Tissue93 |
![]() |
![]() |
— | — | — | — | — | Distal non-cancerous tissue |
Tissue94 |
![]() |
![]() |
![]() |
— | — |
![]() |
![]() |
Adjacent normal tissue |
Tissue95 |
![]() |
— | — | — | — |
![]() |
— | Adjacent normal lung tissue |
Tissue96 |
![]() |
— | — | — | — |
![]() |
— | Normal lung tissue |
Breast | ||||||||
Cell lines97 |
![]() |
![]() |
![]() |
— | — |
![]() |
— | MCF10A cell line |
Cell lines97 |
![]() |
![]() |
![]() |
— | — |
![]() |
— | MCF10A cell line |
Cell lines97 |
![]() |
— |
![]() |
— | — |
![]() |
— | MCF10A cell line |
Cell lines98 |
![]() |
![]() |
![]() |
![]() |
![]() |
— | — | MCF10A cell line |
Cell lines98 |
![]() |
![]() |
![]() |
![]() |
![]() |
— | — | MCF10A cell line |
Tissue94 |
![]() |
![]() |
![]() |
— | — |
![]() |
![]() |
Adjacent normal tissue |
Tissue99 |
![]() |
![]() |
![]() |
— | — |
![]() |
— | Adjacent normal tissue |
Tissue100 |
![]() |
— | — | — | — |
![]() |
— | Adjacent normal breast tissue |
Tissue101 |
![]() |
![]() |
![]() |
— | — |
![]() |
— | Normal breast tissue |
Prostate | ||||||||
Cell lines102 |
![]() |
![]() |
— | — | — |
![]() |
— | PNT1a cell line |
Tissue103 |
![]() |
![]() |
![]() |
— | — |
![]() |
— | Tissue from healthy males |
Colorectal | ||||||||
Tissue104 | — | — | — |
![]() |
![]() |
— |
![]() |
Adjacent normal mucosa |
Tissue94 |
![]() |
![]() |
![]() |
— | — |
![]() |
![]() |
Adjacent normal tissue |
Tissue105 |
![]() |
![]() |
![]() |
— |
![]() |
— | — | Adjacent normal mucosa |
Tissue106 |
![]() |
![]() |
— | — | — | — | — | Adjacent normal mucosa |
Tissue107 |
![]() |
![]() |
— |
![]() |
![]() |
![]() |
— | Tumour adjacent tissue |
Colorectal liver metastasis | ||||||||
Tissue108 |
![]() |
![]() |
![]() |
— |
![]() |
![]() |
— | Normal liver parenchyma |
Ovarian | ||||||||
Tissue109 |
![]() |
— |
![]() |
— | — | — | — | Adjacent normal tissue |
Urothelial cancer of the bladder | ||||||||
Tissue110 |
![]() |
![]() |
![]() |
— |
![]() |
— | — | Benign adjacent tissue |
Gastric | ||||||||
Tissue94 |
![]() |
![]() |
![]() |
— | — |
![]() |
![]() |
Adjacent normal tissue |
Oesophageal | ||||||||
Tissue94 |
![]() |
![]() |
![]() |
— | — |
![]() |
![]() |
Adjacent normal tissue |
Tissue111 | — |
![]() |
![]() |
![]() |
![]() |
— |
![]() |
Matched healthy oesophageal epithelium |
Thyroid | ||||||||
Tissue94 |
![]() |
![]() |
![]() |
— | — |
![]() |
![]() |
Adjacent normal tissue |
Hepatocellular | ||||||||
Tissue112 |
![]() |
![]() |
— | — | — |
![]() |
— | Benign tissue |